IMMULITE(TM) TOTAL T4— 510(k) K910261

Substantially Equivalent

Cirrus Diagnostics, Inc.

FDA 510(k) clearance K910261 for IMMULITE(TM) TOTAL T4, Substantially Equivalent on 1991-04-16. Applicant: Cirrus Diagnostics, Inc.. Device class: 2.

Clearance details

Applicant: Cirrus Diagnostics, Inc.
Product code: Code KLI
Device class: Class 2
Regulation: 21 CFR 862.1700
Advisory panel: Clinical Chemistry
Date received: 1991-01-22
Decision date: 1991-04-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Chester, NJ, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KLI

K160495 — VITROS® Automation Solutions2016-10-18
K131515 — ACE -GT REAGENT; ACE LIPASE RAGENT; ACE T4 REAGENT2013-08-14
K103484 — GSP NEONATAL THYROXINE (T4)2011-04-22
K082638 — ADVIA CENTAUR SYSTEM WITH STREAMLAB ANALYTICAL WORKCELL2009-02-26
K030860 — ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-3002003-08-22

More clearances from Cirrus Diagnostics, Inc.

K921704 — IMMULITE(R) FSH1992-06-09
K920411 — IMMULITE HLH1992-03-11
K914833 — IMMULITE DIGOXIN1991-11-22
K911796 — IMMULITE(TM) HCG1991-06-20
K910677 — IMMULITE(TM) T-UPTAKE1991-04-29

Data sourced from openFDA. This site is unofficial and independent of the FDA.